PHAT
#2667
Phathom Pharmaceuticals, Inc. - Common Stock
9.1 8 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.68%
Variación mensual
+1.44%
Variación en los últimos 6 meses
-24.32%
Cambio anual
-23.37%
Cierres anteriores
8.9 4
Open
9.1 9
Mínimo
9.1 8
Máximo
9.1 9
Volumen
120
Financials
- Market Capitalization 742.67 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.68
Relación precio/flujo de caja
3.54
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2644 |  AURA Aura Biosciences, Inc. - Common Stock | 7.40 USD | -3.90% | -5.13% | +5.56% | +18.40% | 767.42 M USD | ||
| 2657 |  MNPR Monopar Therapeutics Inc. - Common Stock | 111.89 USD | -1.80% | +4.60% | -2.53% | +104.85% | 751.02 M USD | ||
| 2674 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.59 USD | -1.35% | -4.35% | +12.65% | -20.22% | 734.85 M USD | ||
| 2677 |  NGNE Neurogene Inc. - Common Stock | 36.58 USD | -3.38% | -5.33% | +9.19% | +24.34% | 732.02 M USD |